share_log

SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%), etc.

SAB Biotherapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%)等

SEC announcement ·  02/14 06:32
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息